Schizophrenia relapse, patient considerations, and potential role of lurasidone

Overview of attention for article published in Patient preference and adherence, August 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials

Article in Biomedical Reports (April 2024)

Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders

Article in Brain Sciences (February 2023)

Lurasidone for the treatment of schizophrenia in adult and paediatric populations

Article in Drugs in Context (February 2023)